Emergence of Clostridium difficile NAP1 in Latin America

被引：52
|
作者：
Quesada-Gomez, Carlos [1 ,2 ]
Rodriguez, Cesar [1 ,2 ]
del Mar Gamboa-Coronado, Maria [1 ,2 ]
Rodriguez-Cavallini, Evelyn [1 ,2 ]
Du, Tim [3 ]
Mulvey, Michael R. [3 ]
Villalobos-Zuniga, Manuel [4 ]
Boza-Cordero, Ricardo [4 ]
机构：
[1] Univ Costa Rica, Lab Invest Bacteriol Anaerobia, Fac Microbiol, San Jose, Costa Rica
[2] Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, San Jose, Costa Rica
[3] Natl Microbiol Lab, Winnipeg, MB, Canada
[4] Hosp San Juan Dios, San Jose, Costa Rica
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2010年 / 48卷 / 02期
关键词：
TOXIN; EPIDEMIC; STRAIN;
D O I：
10.1128/JCM.02196-09
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：669 / 670
页数：2
相关论文
共 50 条
  • [1] The emergence of Clostridium difficile NAP1 hypervirulent strain in Latin America
    Quesada-Gomez, C.
    Du, T.
    Gamboa-Coronado, M. D. M.
    Rodriguez, C.
    Mulvey, M. R.
    Rodriguez-Cavallini, E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E382 - E382
  • [2] Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama
    Lopez-Urena, Diana
    Quesada-Gomez, Carlos
    Miranda, Erick
    Fonseca, Mercedes
    Rodriguez-Cavallini, Evelyn
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 322 - 324
  • [3] Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America
    Aguayo, C.
    Flores, R.
    Levesque, S.
    Araya, P.
    Ulloa, S.
    Lagos, J.
    Hormazabal, J. C.
    Tognarelli, J.
    Ibanez, D.
    Pidal, P.
    Duery, O.
    Olivares, B.
    Fernandez, J.
    EPIDEMIOLOGY AND INFECTION, 2015, 143 (14): : 3069 - 3073
  • [4] Emergence and control of an outbreak of Clostridium difficile BI/NAP1/027 strain in a comprehensive cancer center
    Vigil, Karen
    Adachi, Javier
    Jiang, Zhi-Dong
    Rathod, Dhanesh
    Burton, Lisa
    Tarrand, Jeffrey
    DuPont, Herbert
    Raad, Issam
    Chemaly, Roy
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : S36 - S36
  • [5] Association of Relapse of Clostridium difficile Disease with BI/NAP1/027
    Marsh, Jane W.
    Arora, Rangolee
    Schlackman, Jessica L.
    Shutt, Kathleen A.
    Curry, Scott R.
    Harrison, Lee H.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (12) : 4078 - 4082
  • [6] First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
    Camacho-Ortiz, Adrian
    Lopez-Barrera, Daniel
    Hernandez-Garcia, Raul
    Galvan-De los Santos, Alejandra M.
    Flores-Trevino, Samantha M.
    Llaca-Diaz, Jorge M.
    Maldonado Garza, Hector J.
    Bosques-Padilla, Francisco J.
    Garza-Gonzalez, Elvira
    PLOS ONE, 2015, 10 (04):
  • [7] NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
    See, Isaac
    Mu, Yi
    Cohen, Jessica
    Beldavs, Zintars G.
    Winston, Lisa G.
    Dumyati, Ghinwa
    Holzbauer, Stacy
    Dunn, John
    Farley, Monica M.
    Lyons, Carol
    Johnston, Helen
    Phipps, Erin
    Perlmutter, Rebecca
    Anderson, Lydia
    Gerding, Dale N.
    Lessa, Fernanda C.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) : 1394 - 1400
  • [8] Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027
    Burns, David A.
    Heeg, Daniela
    Cartman, Stephen T.
    Minton, Nigel P.
    PLOS ONE, 2011, 6 (09):
  • [9] Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole
    Chong, Patrick M.
    Lynch, Tarah
    McCorrister, Stuart
    Kibsey, Pamela
    Miller, Mark
    Gravel, Denise
    Westmacott, Garrett R.
    Mulvey, Michael R.
    PLOS ONE, 2014, 9 (01):
  • [10] Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain
    O'Connor, Jennifer R.
    Johnson, Stuart
    Gerding, Dale N.
    GASTROENTEROLOGY, 2009, 136 (06) : 1913 - 1924
12345